Working… Menu

Chimpanzee Adenovirus and Self-Amplifying mRNA Prime-Boost Prophylactic Vaccines Against SARS-CoV-2 in Healthy Adults

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04776317
Recruitment Status : Recruiting
First Posted : March 1, 2021
Last Update Posted : August 25, 2021
Gritstone Oncology, Inc.
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID)

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : September 19, 2022
Estimated Study Completion Date : September 19, 2022